News
2Seventy Bio
TSVT · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- News
2seventy bio Q1 EPS $0.01 Beats $(0.12) Estimate, Sales $22.94M Beat $13.96M Estimate
- Press releaseBusiness Wire
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BHLB, TSVT, RDFN on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BHLB, TSVT, RDFN on Behalf of Shareholders
- Press releaseBusiness Wire
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
- Press releaseBusiness Wire
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, NDOI, TSVT, RDFN on Behalf of Shareholders
- Press releaseBusiness Wire
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TSVT, BRDG, GB on Behalf of Shareholders
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of 2seventy bio, Inc. - TSVT
- Press releaseBusiness Wire
Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders
- Press releasePRNewswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.
- NewsAvi Kapoor
Crude Oil Gains 1%; Ciena Earnings Top Views
- NewsVandana Singh
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
- NewsAvi Kapoor
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
- Press releaseBusiness Wire
TSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to Shareholders
- NewsRishabh Mishra
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'
- Press releaseBusiness Wire
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
- Press releaseBusiness Wire
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
- NewsVandana Singh
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
- Press releaseBusiness Wire
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
- Press releaseBusiness Wire
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
- News
Earnings Scheduled For November 12, 2024
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT
- Press releaseBusiness Wire
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT
- NewsVandana Singh
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVT
- Press releaseGlobe Newswire
TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm
- Press releaseBusiness Wire
TSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the Firm
- Press releaseBusiness Wire
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.